CN104800891B - A kind of extracellular matrix biomaterial for strengthening In vitro culture mesenchymal stem cell biological anti-oxidation function, preparation method and applications - Google Patents
A kind of extracellular matrix biomaterial for strengthening In vitro culture mesenchymal stem cell biological anti-oxidation function, preparation method and applications Download PDFInfo
- Publication number
- CN104800891B CN104800891B CN201510257496.5A CN201510257496A CN104800891B CN 104800891 B CN104800891 B CN 104800891B CN 201510257496 A CN201510257496 A CN 201510257496A CN 104800891 B CN104800891 B CN 104800891B
- Authority
- CN
- China
- Prior art keywords
- extracellular matrix
- mesenchymal stem
- culture
- stem cells
- mscs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title claims abstract description 60
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title claims abstract description 60
- 210000002744 extracellular matrix Anatomy 0.000 title claims abstract description 60
- 239000012620 biological material Substances 0.000 title claims abstract description 36
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 33
- 238000000338 in vitro Methods 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 230000003064 anti-oxidating effect Effects 0.000 title claims description 6
- 238000005728 strengthening Methods 0.000 title claims 2
- 210000003954 umbilical cord Anatomy 0.000 claims abstract description 11
- 230000002708 enhancing effect Effects 0.000 claims abstract description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 229920001222 biopolymer Polymers 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000012533 medium component Substances 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 239000002953 phosphate buffered saline Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 239000002609 medium Substances 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 230000008859 change Effects 0.000 abstract description 7
- 239000001963 growth medium Substances 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 28
- 230000000694 effects Effects 0.000 description 24
- 239000003642 reactive oxygen metabolite Substances 0.000 description 24
- 102000016938 Catalase Human genes 0.000 description 16
- 108010053835 Catalase Proteins 0.000 description 16
- 238000001514 detection method Methods 0.000 description 15
- 230000035755 proliferation Effects 0.000 description 12
- 101150005399 sod2 gene Proteins 0.000 description 11
- 230000003834 intracellular effect Effects 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 7
- 230000004663 cell proliferation Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 210000000130 stem cell Anatomy 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000001172 regenerating effect Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 210000001612 chondrocyte Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000000703 high-speed centrifugation Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 201000008482 osteoarthritis Diseases 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000008809 cell oxidative stress Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- -1 hydroxyl radicals Chemical class 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- VFNKZQNIXUFLBC-UHFFFAOYSA-N 2',7'-dichlorofluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Cl)=C(O)C=C1OC1=C2C=C(Cl)C(O)=C1 VFNKZQNIXUFLBC-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000008221 Superoxide Dismutase-1 Human genes 0.000 description 1
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000010094 cellular senescence Effects 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 230000009816 chondrogenic differentiation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000010282 redox signaling Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008943 replicative senescence Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 210000002437 synoviocyte Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001644 umbilical artery Anatomy 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供一种增强体外培养间充质干细胞生物抗氧化功能的细胞外基质生物材料、制备方法及其应用,该细胞外基质生物材料的制备步骤如下:脐带间充质干细胞培养在完全培养基中,密度≥90%时,加入完全培养液培养7‑10天,每3天换液一次,之后加入脱细胞液,构建成细胞外基质生物材料。本发明的细胞外基质生物材料能够增强体外培养间充质干细胞生物抗氧化功能。
The invention provides an extracellular matrix biological material for enhancing the biological antioxidant function of in vitro cultured mesenchymal stem cells, a preparation method and its application. The preparation steps of the extracellular matrix biological material are as follows: umbilical cord mesenchymal stem cells are cultured in a complete culture medium In medium, when the density is ≥90%, add complete culture medium to culture for 7‑10 days, change the medium every 3 days, and then add decellularized medium to construct extracellular matrix biomaterials. The extracellular matrix biological material of the present invention can enhance the biological antioxidant function of mesenchymal stem cells cultured in vitro.
Description
技术领域technical field
本发明属于生物医学领域,尤其涉及一种增强体外培养间充质干细胞生物抗氧化功能的细胞外基质生物材料、制备方法及其应用。The invention belongs to the field of biomedicine, and in particular relates to an extracellular matrix biological material for enhancing the biological antioxidant function of in vitro cultured mesenchymal stem cells, a preparation method and an application thereof.
背景技术Background technique
间充质干细胞(mesenchymal stem cells,MSCs)是一种负责组织再生和修复的成体干细胞,最初发现于骨髓中,由于其再生和免疫调节的潜能,已在各大领域引起广泛的关注。人类脐带间充质干细胞,尤其是来源于Wharton's jelly(脐带中包绕两条脐动脉和一条脐静脉黏蛋白样结缔组织)被认为是细胞治疗和再生医学中理想的种子细胞。脐带是一种胚胎外组织,因此脐带间充质干细胞具备胚胎干细胞和成体干细胞的双重特性,其自我更新及多向分化潜能明显优于骨髓间充质干细胞。Mesenchymal stem cells (MSCs) are adult stem cells responsible for tissue regeneration and repair. They were originally discovered in the bone marrow. Due to their potential for regeneration and immune regulation, they have attracted widespread attention in various fields. Human umbilical cord mesenchymal stem cells, especially those derived from Wharton's jelly (the mucin-like connective tissue surrounding two umbilical arteries and one umbilical vein in the umbilical cord) are considered ideal seed cells for cell therapy and regenerative medicine. The umbilical cord is an extraembryonic tissue, so umbilical cord mesenchymal stem cells have dual characteristics of embryonic stem cells and adult stem cells, and their self-renewal and multidirectional differentiation potentials are significantly better than bone marrow mesenchymal stem cells.
有越来越多的证据表明,活性氧(ROS)对细胞增殖、分化、死亡、基质环境的稳态、氧化还原信号机制等是必不可少的,但细胞异常水平的ROS会导致DNA、蛋白质、脂类不可逆转的损害,最终细胞走向衰老和死亡的命运。There is increasing evidence that reactive oxygen species (ROS) are essential for cell proliferation, differentiation, death, homeostasis of the matrix environment, redox signaling mechanisms, etc., but abnormal levels of ROS in cells can lead to DNA, protein , Irreversible damage to lipids, and eventually the cells move towards the fate of aging and death.
尽管MSCs在再生医学中的应用得到广泛关注,但其在体外扩增和体内移植过程中却不可避免的暴露于相当大的氧化应激之下,造成ROS(如过氧化氢、羟基自由基、超氧化物阴离子自由基)超标。体外长期培养的MSCs内H2O2水平增加,导致细胞衰老和增殖抑制。骨性关节炎和类风湿关节炎患者体内软骨细胞或中性粒细胞和巨噬细胞产生异常水平的ROS,影响MSCs的再生潜力。研究表明,ROS的累积是由于接触炎症细胞因子引起,从而抑制干细胞的细胞增殖和多向分化潜能。Although the application of MSCs in regenerative medicine has received extensive attention, they are inevitably exposed to considerable oxidative stress during in vitro expansion and in vivo transplantation, causing ROS (such as hydrogen peroxide, hydroxyl radicals, superoxide anion free radical) exceeded the standard. Increased H2O2 levels in long - term cultured MSCs in vitro lead to cellular senescence and inhibition of proliferation. Chondrocytes or neutrophils and macrophages in patients with osteoarthritis and rheumatoid arthritis produce abnormal levels of ROS, affecting the regenerative potential of MSCs. Studies have shown that the accumulation of ROS is caused by exposure to inflammatory cytokines, thereby inhibiting the cell proliferation and multilineage differentiation potential of stem cells.
ROS生成和消除之间的平衡对细胞生存、增殖、分化至关重要。超氧化物歧化酶(SOD),包括含有铜、锌(SOD1和 SOD2)和锰(SOD2)的同功酶,保护MSCs免受超氧化物阴离子催化生成的H2O2的活性氧损害。氧化应激可以消除SOD2引起的人类滑膜起源的间充质干细胞的软骨分化能力下降和基质金属蛋白酶的表达增加。此外,SOD产生的H2O2被过氧化氢酶(catalase)所中和,先前的大量研究表明,提高MSCs内的catalase活性有利于缓解H2O2诱导的细胞凋亡。The balance between ROS generation and elimination is critical for cell survival, proliferation, and differentiation. Superoxide dismutase (SOD), including isozymes containing copper, zinc (SOD1 and SOD2), and manganese (SOD2), protects MSCs from reactive oxygen species generated by H2O2 catalyzed by superoxide anion . Oxidative stress can abolish SOD2-induced decreased chondrogenic differentiation ability and increased expression of matrix metalloproteinases in human synovium-derived mesenchymal stem cells. In addition, the H 2 O 2 produced by SOD is neutralized by catalase. A large number of previous studies have shown that increasing the activity of catalase in MSCs is beneficial to alleviate the apoptosis induced by H 2 O 2 .
MSC起源的细胞外基质(ECM)组分包含 I型和III型胶原蛋白,纤连蛋白、层粘连蛋白,可以充当体外培养系统的微环境,促进MSC扩增、指引MSC向特定方向分化。脱细胞的ECM不仅可以模拟体内干细胞细胞外微环境,还可调节生长因子和激素的生物学行为。这种运用脱细胞的ECM的培养方法可防止细胞复制衰老,增强终末分化细胞的再分化能力,如软骨细胞和髓核细胞。最近的研究表明,脱细胞的ECM能改善骨髓间充质干细胞抵抗H2O2诱导的氧化应激和细胞周期停滞。然而, ECM对脐带间充质干细胞内抗氧化系统的影响却鲜有人知。The extracellular matrix (ECM) components derived from MSCs contain type I and type III collagens, fibronectin, and laminin, which can serve as a microenvironment for in vitro culture systems, promote MSC expansion, and guide MSCs to differentiate in specific directions. Decellularized ECM can not only simulate the extracellular microenvironment of stem cells in vivo, but also regulate the biological behavior of growth factors and hormones. This culture method using decellularized ECM can prevent cell replicative senescence and enhance the redifferentiation ability of terminally differentiated cells, such as chondrocytes and nucleus pulposus cells. Recent studies have shown that decellularized ECM can improve the resistance of BMSCs to H2O2 - induced oxidative stress and cell cycle arrest. However, little is known about the effect of ECM on the antioxidant system in umbilical cord mesenchymal stem cells.
发明内容Contents of the invention
解决的技术问题:针对现有的MSCs在体外扩增和体内移植过程中不可避免的暴露于相当大的氧化应激之下,造成ROS超标的缺点,本发明提供一种增强体外培养间充质干细胞生物抗氧化功能的细胞外基质生物材料、制备方法及其应用,通过脐带间充质干细胞分泌基质制备细胞外基质生物材料,不仅具有多种蛋白质成分的特征,而且能用于间充质干细胞的体外扩增,具有生物相容性好、增殖效率高、显著降低细胞内活性氧含量的优点。Technical problem to be solved: Aiming at the disadvantage that existing MSCs are inevitably exposed to considerable oxidative stress during in vitro expansion and in vivo transplantation, resulting in excessive ROS, the present invention provides an enhanced in vitro cultured mesenchymal Extracellular matrix biomaterials with anti-oxidation function of stem cells, preparation method and application, extracellular matrix biomaterials are prepared by secreting matrix of umbilical cord mesenchymal stem cells, which not only have the characteristics of various protein components, but also can be used for mesenchymal stem cells The in vitro expansion has the advantages of good biocompatibility, high proliferation efficiency, and significantly reduced intracellular active oxygen content.
技术方案:Technical solutions:
本发明的检测内容包括:(1)细胞外基质生物材料对UC-MSCs增殖能力的影响;(2)细胞外基质生物材料对UC-MSCs内ROS和H2O2 表达的影响;(3)细胞外基质生物材料对UC-MSCs内SOD-2表达的影响;(4)细胞外基质生物材料对UC-MSCs内Catalase活性的影响。The detection content of the present invention includes: (1) the influence of extracellular matrix biological material on the proliferation ability of UC-MSCs; (2) the influence of extracellular matrix biological material on the expression of ROS and H 2 O 2 in UC-MSCs; (3) The effect of extracellular matrix biomaterials on the expression of SOD-2 in UC-MSCs; (4) the effect of extracellular matrix biomaterials on Catalase activity in UC-MSCs.
上述所述的内容通过以下步骤实现:The content described above is achieved through the following steps:
(A)脐带间充质干细胞(umbilical cord-derived mesenchymal stem cells ,UC-MSCs)培养在完全培养基中(完全培养基组分为α-MEM和胎牛血清,它们的体积比为(4-9):1,并且含有抗生素,抗生素的含量为10~200 U/mL),密度≥90%时,加入含有抗坏血酸(100-200uM)的完全培养液培养7-10天,每3天换液一次,之后加入脱细胞液(由pH值为7.4的磷酸盐缓冲液配制,含有Triton X-100 0.5~5% 体积比和氨水10-40mM),构建成细胞外基质生物材料;(A) Umbilical cord-derived mesenchymal stem cells (UC-MSCs) were cultured in complete medium (the components of the complete medium were α-MEM and fetal bovine serum, and their volume ratio was (4- 9): 1, and contains antibiotics, the content of antibiotics is 10~200 U/mL), when the density is ≥90%, add complete culture medium containing ascorbic acid (100-200uM) and cultivate for 7-10 days, and change the medium every 3 days Once, add decellularization solution (prepared from phosphate buffer with a pH value of 7.4, containing Triton X-100 0.5-5% volume ratio and ammonia water 10-40mM) to construct extracellular matrix biomaterials;
(B)UC-MSCs分别培养在普通的孔板(TCPS板)和底部铺有细胞外基质生物材料的孔板(ECM板)中,在不同的时间点检测孔板中DNA含量,二乙酸荧光素(FDA)染色记录不同时间点的细胞数量及形态变化;(B) UC-MSCs were cultured in ordinary well plates (TCPS plates) and well plates with extracellular matrix biomaterials on the bottom (ECM plates), and the DNA content in the well plates was detected at different time points, and diacetic acid fluorescence Cell number and morphological changes at different time points were recorded by FDA staining;
(C)检测TCPS板和ECM板上UC-MSCs内ROS和H2O2含量;(C) Detection of ROS and H 2 O 2 contents in UC-MSCs on TCPS plate and ECM plate;
(D)检测TCPS板和ECM板上UC-MSCs内SOD-2含量和Catalase活性。(D) Detection of SOD-2 content and Catalase activity in UC-MSCs on TCPS plate and ECM plate.
所述UC-MSCs取自人源、猪源、鼠源或兔源。The UC-MSCs are obtained from human, porcine, mouse or rabbit sources.
所述细胞外基质生物材料可应用于包括细胞移植治疗和再生医学等领域。The extracellular matrix biomaterial can be applied in fields including cell transplantation therapy and regenerative medicine.
上述所述的内容具体分析步骤如下:The specific analysis steps of the above content are as follows:
(1)FDA染色、DNA定量检测分析细胞外基质生物材料对UC-MSCs增殖能力的影响。(1) FDA staining and DNA quantitative detection were used to analyze the effects of extracellular matrix biomaterials on the proliferation ability of UC-MSCs.
(2)DCF-DA荧光定量法检测细胞内ROS水平。(2) DCF-DA fluorescence quantitative method was used to detect the level of intracellular ROS.
(3)H2O2检测试剂盒检测细胞内H2O2水平。(3) H 2 O 2 detection kit detects intracellular H 2 O 2 level.
(4)Western bort检测细胞内SOD-2含量。(4) Western bort detection of intracellular SOD-2 content.
(5)Catalase活性检测试剂盒检测细胞内Catalase活性水平。(5) Catalase activity detection kit detects the level of Catalase activity in cells.
H2O2是ROS主要成分之一,在细胞增殖中起着双重作用。低水平的H2O2 (<10μM)刺激成纤维细胞生长,而细胞暴露于高浓度的H2O2 (>400μM)则会快速凋亡。本发明的方案表明,细胞外基质生物材料培养细胞的细胞内H2O2水平下降,是支持细胞体外生存和快速增殖的一个重要原因。此外,超氧化物阴离子以剂量依赖的方式影响细胞增殖,低水平的超氧化物阴离子刺激细胞增殖,浓度增加则会抑制细胞生长。H 2 O 2 is one of the main components of ROS and plays a dual role in cell proliferation. Low levels of H 2 O 2 (<10 μM) stimulate fibroblast growth, while cells exposed to high concentrations of H 2 O 2 (>400 μM) undergo rapid apoptosis. The protocol of the present invention shows that the decreased intracellular H 2 O 2 level of cells cultured with extracellular matrix biomaterial is an important reason for supporting the survival and rapid proliferation of cells in vitro. In addition, superoxide anion affects cell proliferation in a dose-dependent manner, with low levels of superoxide anion stimulating cell proliferation and increasing concentrations inhibiting cell growth.
增强抗氧化能力引起UC-MSCs中ROS水平下降,临床治疗方面有着广泛的应用。骨性关节炎中软骨细胞的SOD-2活性受损不仅导致其氧化损伤,还能加快骨性关节炎的发病进程。Enhanced antioxidant capacity causes a decrease in ROS levels in UC-MSCs, which has a wide range of clinical applications. The impaired SOD-2 activity of chondrocytes in osteoarthritis not only leads to their oxidative damage, but also accelerates the pathogenesis of osteoarthritis.
MSCs广泛应用于细胞移植治疗和组织工程的研发,然而病理条件下超标的ROS产生的炎症细胞因子改变了MSCs的某些特性,影响其生存。因此在体内移植的过程中,防止细胞氧化应激损伤和提高细胞存活率显得尤为重要。先前的研究证明细胞培养在源自滑膜细胞或骨髓细胞的脱细胞ECM显著降低ROS水平,这样阐明ECM调控细胞内抗氧化防御的潜在分子机制将变得很有意义。MSCs are widely used in the research and development of cell transplantation therapy and tissue engineering. However, the inflammatory cytokines produced by excessive ROS under pathological conditions change some characteristics of MSCs and affect their survival. Therefore, in the process of in vivo transplantation, it is particularly important to prevent cell oxidative stress damage and improve cell survival rate. Previous studies have demonstrated that cell culture in decellularized ECM derived from synoviocytes or bone marrow cells significantly reduces ROS levels, so it will be interesting to elucidate the underlying molecular mechanism by which ECM regulates intracellular antioxidant defense.
有益效果:本发明提供的一种增强体外培养间充质干细胞生物抗氧化功能的细胞外基质生物材料、制备方法及其应用,MSCs在该细胞外基质生物材料中培养比在TCPS板上培养的细胞内抗氧化活性的酶表达水平更高,尤其是SOD-2和Catalase;SOD-2和Catalase活性增强导致ROS和H2O2水平减少,因此细胞外基质生物材料能够增强体外培养间充质干细胞生物抗氧化功能。Beneficial effect: the invention provides a kind of extracellular matrix biological material, preparation method and application thereof that enhances the biological antioxidant function of in vitro cultured mesenchymal stem cells. Higher expression levels of enzymes with antioxidant activity in cells, especially SOD- 2 and Catalase; enhanced SOD- 2 and Catalase activities lead to decreased ROS and H2O2 levels, so extracellular matrix biomaterials can enhance mesenchymal in vitro Antioxidant function of stem cells.
附图说明Description of drawings
图1为FDA染色记录不同时间点TCPS板和ECM板上UC-MSCs的增殖情况图。Figure 1 is a graph showing the proliferation of UC-MSCs on TCPS plates and ECM plates at different time points recorded by FDA staining.
图2为DNA定量检测分析不同时间点TCPS板和ECM板上UC-MSCs的增殖情况图。Figure 2 is a graph showing the proliferation of UC-MSCs on TCPS plates and ECM plates at different time points by DNA quantitative detection and analysis.
图3为TCPS板和ECM板上UC-MSCs内ROS和H2O2含量变化图。Fig. 3 is a graph showing the changes of ROS and H 2 O 2 content in UC-MSCs on TCPS plate and ECM plate.
图4为TCPS板和ECM板上UC-MSCs内SOD-2含量变化图。Figure 4 is a graph showing the change of SOD-2 content in UC-MSCs on the TCPS plate and the ECM plate.
图5为TCPS板和ECM板上UC-MSCs内Catalase活性变化图。Fig. 5 is a graph showing the change of Catalase activity in UC-MSCs on the TCPS plate and the ECM plate.
具体实施方式detailed description
下面结合具体实施例对本发明作进一步的解释说明,但具体实施例并不对本发明作任何限定。除非特别说明,实施例中所涉及的试剂、方法均为本领域常用的试剂和方法。The present invention will be further explained below in conjunction with specific examples, but the specific examples do not limit the present invention in any way. Unless otherwise specified, the reagents and methods involved in the examples are commonly used reagents and methods in the art.
实施例1Example 1
具体实验步骤如下:The specific experimental steps are as follows:
(1)人源UC-MSCs在37℃、5%CO2 培育箱中培养于175cm2培养瓶中,每三天换一次液,其中培养基各组分的体积比为89%的α-MEM,10%的胎牛血清,1%的青霉素、链霉素;(1) Human UC-MSCs were cultured in a 175cm 2 culture flask in a 37°C, 5% CO 2 incubator, and the liquid was changed every three days, and the volume ratio of each component of the medium was 89% α-MEM , 10% fetal bovine serum, 1% penicillin, streptomycin;
(2)当细胞密度≥90%时用0.25% trypsin-EDTA消化细胞,按5000/cm2密度接种于预处理的多种规格的孔板中培养,直到达到90%融合,加入100μM 抗坏血酸继续培养8天,三天换液一次,其中接种方法为TCPS板用0.2%明胶在37℃环境下孵育1小时,接着用1%戊二醛和1M乙醇胺在室温下孵育30分钟,多种规格的板分为12孔板用于FDA染色、DNA定量检测,6孔板用于ROS、H2O2、Catalase含量测定,75cm2培养瓶用于SOD-2蛋白分析;(2) When the cell density is ≥90%, digest the cells with 0.25% trypsin-EDTA, inoculate them at a density of 5000/cm 2 in pretreated well plates of various specifications, and culture them until they reach 90% confluence, then add 100 μM ascorbic acid to continue the culture For 8 days, change the medium once every three days. The inoculation method is to incubate the TCPS plate with 0.2% gelatin at 37°C for 1 hour, then incubate with 1% glutaraldehyde and 1M ethanolamine at room temperature for 30 minutes. Various specifications of the plate Divided into 12-well plates for FDA staining and DNA quantitative detection, 6-well plates for ROS, H 2 O 2 , and Catalase content determination, and 75cm 2 culture flasks for SOD-2 protein analysis;
(3)8天后为了获得游离的细胞外基质生物材料,培养细胞加入脱细胞混合液,于37℃环境下孵育5分钟,其中脱细胞混合液由pH值为7.4 的磷酸盐缓冲液配制,含有0.5%Triton X-100和20mM氨水;(3) After 8 days, in order to obtain free extracellular matrix biomaterials, the cultured cells were added to the decellularized mixture and incubated at 37°C for 5 minutes. The decellularized mixture was prepared from a phosphate buffer with a pH value of 7.4, containing 0.5% Triton X-100 and 20mM ammonia water;
(4)将脱细胞的细胞外基质生物材料用PBS 清洗3次,最后一次用含有1X双抗的PBS清洗并保留在孔板中,4℃存储在无菌环境中备用。(4) The decellularized extracellular matrix biological material was washed 3 times with PBS, and the last time was washed with PBS containing 1X double antibody and kept in the well plate, and stored in a sterile environment at 4°C for future use.
(5)UC-MSCs以5000/cm2密度分别接种在TCPS板和ECM板中,于37℃、5%CO2环境下培养。(5) UC-MSCs were seeded on TCPS plates and ECM plates at a density of 5000/cm 2 , and cultured at 37°C and 5% CO 2 .
检测项目和方法如下:The detection items and methods are as follows:
1、细胞外基质生物材料对UC-MSCs增殖能力、胞内ROS、H2O2水平的影响。1. Effects of extracellular matrix biomaterials on UC-MSCs proliferation ability, intracellular ROS and H 2 O 2 levels.
A. 细胞外基质生物材料对UC-MSCs增殖能力的影响。A. The effect of extracellular matrix biomaterials on the proliferation ability of UC-MSCs.
细胞生存能力采用FDA染色评估,分别于第1,3,5,7天用FDA染色,细胞被PBS清洗一次后用5μg/ml FDA染液在37℃避光孵育 10分钟,PBS洗涤一次后,用Olympus IX51 倒置显微镜拍照,其中FDA用丙酮配成1000X储存浓度,使用时用培养液稀释;The cell viability was evaluated by FDA staining. The cells were stained with FDA on the 1st, 3rd, 5th, and 7th day respectively. After the cells were washed once with PBS, they were incubated with 5 μg/ml FDA dye solution at 37°C for 10 minutes in the dark, and then washed once with PBS. Take pictures with an Olympus IX51 inverted microscope, where the FDA uses acetone to make a 1000X storage concentration, and dilute it with culture medium when used;
细胞增殖由DNA定量检测分析评估,使用Quant-iTTM PicoGreen®dsDNA分析试剂盒。分别在第1,3,5,7天用胰酶消化细胞,将DNA样品收集在1.5ml EP管中,高速离心后去除上清液,每组收集4管。每管加入200μL木瓜蛋白酶溶解缓冲液(溶解在PBS中的终浓度为125μg /ml),60℃水浴4小时,让细胞充分裂解。相同数量的溶解产物和反应试剂添加到96孔板中,室温避光孵育5分钟,用SynergyMx多功能酶标仪在485/520 nm(激发波长/发射波长)下测定样品的荧光强度,每组设置6个复孔。Cell proliferation was assessed by quantitative DNA assay using the Quant-iT TM PicoGreen ® dsDNA Assay Kit. The cells were digested with trypsin on days 1, 3, 5, and 7 respectively, and the DNA samples were collected in 1.5ml EP tubes. After high-speed centrifugation, the supernatant was removed, and 4 tubes were collected for each group. Add 200 μL of papain lysis buffer (final concentration of 125 μg/ml dissolved in PBS) to each tube, and bathe in water at 60°C for 4 hours to fully lyse the cells. The same amount of lysates and reaction reagents were added to a 96-well plate, incubated at room temperature in the dark for 5 minutes, and the fluorescence intensity of the sample was measured at 485/520 nm (excitation wavelength/emission wavelength) with a SynergyMx multifunctional microplate reader. Set up 6 replicate holes.
检测结果如图1和图2所示,细胞外基质生物材料明显提高UC-MSCs的增殖能力。FDA染色表明培养在ECM上的干细胞形态呈现出纺锤型,各个时间点细胞数量明显多于TCPS组(Scale bar = 100 μm); ECM板上各个时间点DNA含量显著多于TCPS板。As shown in Figure 1 and Figure 2, the test results show that the extracellular matrix biomaterial significantly improves the proliferation ability of UC-MSCs. FDA staining showed that the morphology of stem cells cultured on ECM showed a spindle shape, and the number of cells at each time point was significantly more than that of the TCPS group (Scale bar = 100 μm); the DNA content of each time point on the ECM plate was significantly higher than that on the TCPS plate.
B. 细胞外基质生物材料对UC-MSCs内ROS和H2O2含量变化的影响。B. Effects of extracellular matrix biomaterials on the changes of ROS and H 2 O 2 contents in UC-MSCs.
DCF-DA荧光定量法检测细胞内ROS水平。每管至少收集2×105个细胞,在10μM 2′,7′二氯荧光素二乙酸(DCF-DA)中37ºC避光水浴30分钟。使用Cytomics FC500流式细胞分析仪测量荧光强度。The intracellular ROS level was detected by DCF-DA fluorescence quantification method. Collect at least 2×10 5 cells per tube, and bathe in 10 μM 2′,7′ dichlorofluorescein diacetic acid (DCF-DA) at 37ºC in the dark for 30 minutes. Fluorescence intensity was measured using a Cytomics FC500 flow cytometer.
细胞内H2O2水平的检测运用Amplex® Red Hydrogen Peroxide检测试剂盒。培养在TCPS板和ECM板上的细胞用细胞裂解液裂解后提取上清液,裂解产物与反应试剂混合后孵育30分钟。用SynergyMx多功能酶标仪在530/590 nm (激发波长/发射波长)测定样品的荧光强度。Intracellular H 2 O 2 levels were detected using the Amplex ® Red Hydrogen Peroxide Detection Kit. The cells cultured on the TCPS plate and the ECM plate were lysed with the cell lysate and the supernatant was extracted, and the lysate was mixed with the reaction reagent and incubated for 30 minutes. The fluorescence intensity of the samples was measured at 530/590 nm (excitation wavelength/emission wavelength) with a SynergyMx multifunctional microplate reader.
检测结果如图3所示,ECM板上UC-MSCs内ROS和H2O2含量显著低于TCPS板。The detection results are shown in Figure 3. The ROS and H 2 O 2 contents in UC-MSCs on the ECM plate were significantly lower than those on the TCPS plate.
2、细胞外基质生物材料对UC-MSCs内SOD-2含量及Catalase活性变化的影响。2. The effect of extracellular matrix biomaterials on the changes of SOD-2 content and Catalase activity in UC-MSCs.
A. 细胞外基质生物材料对UC-MSCs内SOD-2含量变化的影响A. Effect of extracellular matrix biomaterials on the change of SOD-2 content in UC-MSCs
75cm2培养瓶培养的细胞外基质生物材料细胞用胰酶消化后转移到1.5ml EP管中,高速离心后去除上清液,每管加入含有蛋白酶抑制剂的细胞裂解液100ul冰上裂解30分钟,高速离心后取上清液,使用BCA蛋白定量试剂盒(碧云天)测定蛋白浓度。等量提取的蛋白在10%聚丙烯酰胺凝胶中变性和分离,然后由电泳转移到硝酸纤维素膜上,膜在PBS稀释过的SOD-2,α-tubulin抗体中4℃过夜孵育,接着膜在稀释的辣根过氧化物酶中继续孵育1小时,加入化学发光试剂盒后曝光显影,使用ImageJ软件对目标蛋白量化。The extracellular matrix biomaterial cells cultured in a 75cm2 culture flask were digested with trypsin and transferred to a 1.5ml EP tube. After high-speed centrifugation, the supernatant was removed, and 100ul of cell lysate containing protease inhibitors was added to each tube to lyse on ice for 30 minutes. , and the supernatant was taken after high-speed centrifugation, and the protein concentration was determined using the BCA protein quantification kit (Beiyuntian). Equal amounts of extracted proteins were denatured and separated in 10% polyacrylamide gel, and then transferred to nitrocellulose membrane by electrophoresis. The membrane was incubated overnight at 4°C in SOD-2 diluted in PBS, α-tubulin antibody, and then The membrane was further incubated in diluted horseradish peroxidase for 1 hour, exposed and developed after adding a chemiluminescent kit, and the target protein was quantified using ImageJ software.
检测结果如图4所示,细胞外基质生物材料明显增加UC-MSCs内SOD-2含量。The detection results are shown in Figure 4, the extracellular matrix biomaterial significantly increased the SOD-2 content in UC-MSCs.
B. 细胞外基质生物材料对UC-MSCs内Catalase活性的影响B. Effect of extracellular matrix biomaterials on Catalase activity in UC-MSCs
细胞内Catalase活性水平的检测运用商用Catalase活性检测试剂盒。培养在TCPS板和ECM板上的细胞用细胞裂解液裂解后提取蛋白上清液,总蛋白使用BCA蛋白定量试剂盒测定,每组等量的蛋白样品与试剂盒中的比色反应底物溶液混合后室温孵育15分钟,尽快用酶标仪测定样品在520 nm处的吸光度。Intracellular Catalase activity level was detected using a commercial Catalase activity detection kit. The cells cultured on the TCPS plate and the ECM plate were lysed with cell lysate and the protein supernatant was extracted. The total protein was determined using the BCA protein quantification kit, and the equal amount of protein samples in each group was reacted with the colorimetric substrate solution in the kit. After mixing, incubate at room temperature for 15 minutes, and measure the absorbance of the sample at 520 nm with a microplate reader as soon as possible.
检测结果如图5所示,细胞外基质生物材料明显提高UC-MSCs内Catalase活性水平。The detection results are shown in Figure 5, the extracellular matrix biomaterial significantly increased the Catalase activity level in UC-MSCs.
综上实验表明,细胞外基质生物材料能明显提高UC-MSCs的增殖能力,降低UC-MSCs内ROS和H2O2含量,增加UC-MSCs内SOD-2含量,提高UC-MSCs内Catalase活性水平,有效预防干细胞氧化应激损害,在细胞移植治疗和再生医学等领域着广泛的应用前景。In summary, the above experiments show that extracellular matrix biomaterials can significantly improve the proliferation ability of UC-MSCs, reduce the content of ROS and H 2 O 2 in UC-MSCs, increase the content of SOD-2 in UC-MSCs, and increase the activity of Catalase in UC-MSCs level, effectively prevent stem cell oxidative stress damage, and have broad application prospects in the fields of cell transplantation therapy and regenerative medicine.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510257496.5A CN104800891B (en) | 2015-05-20 | 2015-05-20 | A kind of extracellular matrix biomaterial for strengthening In vitro culture mesenchymal stem cell biological anti-oxidation function, preparation method and applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510257496.5A CN104800891B (en) | 2015-05-20 | 2015-05-20 | A kind of extracellular matrix biomaterial for strengthening In vitro culture mesenchymal stem cell biological anti-oxidation function, preparation method and applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104800891A CN104800891A (en) | 2015-07-29 |
CN104800891B true CN104800891B (en) | 2017-03-29 |
Family
ID=53686365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510257496.5A Expired - Fee Related CN104800891B (en) | 2015-05-20 | 2015-05-20 | A kind of extracellular matrix biomaterial for strengthening In vitro culture mesenchymal stem cell biological anti-oxidation function, preparation method and applications |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104800891B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105854084A (en) * | 2016-04-01 | 2016-08-17 | 苏州大学附属第医院 | Extracellular matrix biomaterial for resisting cell premature senility and preparation method and application thereof |
CN107308497B (en) * | 2017-06-09 | 2019-11-26 | 浙江大学 | Construction of nucleus pulposus cell-derived active microcarrier |
CN107550935A (en) * | 2017-09-11 | 2018-01-09 | 上海亚睿生物科技有限公司 | A kind of biological gel for treating joint disease and its application |
CN108546675A (en) * | 2018-05-17 | 2018-09-18 | 广东芙金干细胞再生医学有限公司 | Stem cell is promoted to be divided into the preparation method of the extracellular matrix of liver cell |
CN112280735B (en) * | 2020-09-16 | 2022-03-29 | 生物岛实验室 | Umbilical cord-derived mesenchymal stem cells and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055348A (en) * | 2011-10-24 | 2013-04-24 | 北京清美联创干细胞科技有限公司 | Preparation method and application of autologous mesenchymal stem cell-loaded human amniotic membrane cornea paster |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102892880A (en) * | 2010-01-14 | 2013-01-23 | 奥加诺吉尼西斯公司 | Bioengineered tissue constructs and methods for producing and using thereof |
CN104342402B (en) * | 2013-07-30 | 2017-03-15 | 苏州大学 | A kind of bone marrow dedifferentes the cultural method of mescenchymal stem cell |
-
2015
- 2015-05-20 CN CN201510257496.5A patent/CN104800891B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055348A (en) * | 2011-10-24 | 2013-04-24 | 北京清美联创干细胞科技有限公司 | Preparation method and application of autologous mesenchymal stem cell-loaded human amniotic membrane cornea paster |
Also Published As
Publication number | Publication date |
---|---|
CN104800891A (en) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104800891B (en) | A kind of extracellular matrix biomaterial for strengthening In vitro culture mesenchymal stem cell biological anti-oxidation function, preparation method and applications | |
CN103380769B (en) | For separating of the long-time conserving liquid of the fatty tissue of culturing stem cells | |
CN112048470B (en) | Method for preparing clinical grade mesenchymal stem cell preparation by using human induced pluripotent stem cells | |
EP3933032A1 (en) | Three-dimensional culture method for large-scale preparation of stem cells | |
CN107557331A (en) | A kind of method for separating and cultivating human adipose-derived stem cell | |
CN109628373B (en) | Method for harvesting cells on three-dimensional microcarrier | |
Li et al. | CGF membrane promotes periodontal tissue regeneration mediated by hUCMSCs through upregulating TAZ and osteogenic differentiation genes | |
CN105039248B (en) | Tree shrew mesenchymal stem cell culture systems | |
EP2723850B1 (en) | Method for cultivating cells in platelet-lysate-containing medium | |
CN113287603A (en) | Biological sample preservation solution and preparation method and application thereof | |
CN108865977A (en) | A kind of newborn rat skin end septal cell massive amplification method and application | |
Vanawati et al. | Comparison of human Mesenchymal Stem Cells biocompatibility data growth on gelatin and silk fibroin scaffolds | |
Jalili‐Firoozinezhad et al. | Influence of decellularized pericardium matrix on the behavior of cardiac progenitors | |
US20250154474A1 (en) | Preservation solution for cryopreservation of adipose-derived mesenchymal stem cells | |
CN111849878A (en) | A method for improving the osteogenic ability of mesenchymal stem cells | |
CN117946529A (en) | A hydrogel and its application in amplifying and culturing mesenchymal stem cells | |
Du et al. | Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism | |
CN114752590B (en) | Efficient and economical separation method of pig muscle stem cells and application thereof | |
CN112342189B (en) | A method for inducing myogenic differentiation of adipose-derived mesenchymal stem cells | |
Tragoonlugkana et al. | The use of human platelet lysate as a coating substance for adipose-derived stem cell expansion | |
WO2023001147A1 (en) | Preservation solution for low-temperature long-term preservation of adipose-derived mesenchymal stem cell | |
CN113717933A (en) | Application of FGF7 in preparation of stem cell expansion and phenotype maintenance reagent | |
CN111909891A (en) | Extracellular matrix biological material generated by embryonic stem cells and preparation method and application thereof | |
Frolova et al. | Preparation of a Single-Cell Suspension from Tumor Biopsy Samples for Single-Cell RNA Sequencing | |
CN105854084A (en) | Extracellular matrix biomaterial for resisting cell premature senility and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170329 Termination date: 20200520 |